At close: December 13 at 1:30:34 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,567,506.00
1,593,502.00
1,291,692.00
1,028,183.00
1,009,308.00
Cost of Revenue
962,288.00
990,448.00
839,162.00
673,601.00
691,266.00
Gross Profit
605,218.00
603,054.00
452,530.00
354,582.00
318,042.00
Operating Expense
360,750.00
337,432.00
297,042.00
192,893.00
173,589.00
Operating Income
244,468.00
265,622.00
155,488.00
161,689.00
144,453.00
Net Non Operating Interest Income Expense
25,130.00
23,446.00
8,926.00
3,136.00
5,429.00
Pretax Income
276,604.00
297,305.00
178,162.00
173,821.00
148,690.00
Tax Provision
54,179.00
59,543.00
38,301.00
32,132.00
32,048.00
Net Income Common Stockholders
196,605.00
210,319.00
137,111.00
123,206.00
115,995.00
Diluted NI Available to Com Stockholders
196,605.00
210,319.00
137,111.00
123,206.00
115,995.00
Basic EPS
5.41
5.79
3.77
3.40
3.20
Diluted EPS
5.39
5.77
3.76
3.38
3.18
Basic Average Shares
36,314.33
36,300.00
36,300.00
36,300.00
36,300.00
Diluted Average Shares
36,459.97
36,439.70
36,457.30
36,483.92
36,489.97
Total Expenses
1,323,038.00
1,327,880.00
1,136,204.00
866,494.00
864,855.00
Net Income from Continuing & Discontinued Operation
196,605.00
210,319.00
137,111.00
123,206.00
115,995.00
Normalized Income
198,372.47
207,970.21
134,879.97
124,242.05
118,822.99
Interest Income
29,933.00
25,893.00
10,251.00
4,008.00
6,439.00
Interest Expense
4,803.00
2,447.00
1,325.00
872.00
1,010.00
Net Interest Income
25,130.00
23,446.00
8,926.00
3,136.00
5,429.00
EBIT
281,407.00
299,752.00
179,487.00
174,693.00
149,700.00
EBITDA
452,506.00
448,711.00
294,893.00
270,885.00
230,174.00
Reconciled Cost of Revenue
962,288.00
990,448.00
839,162.00
673,601.00
691,266.00
Reconciled Depreciation
171,099.00
148,959.00
115,406.00
96,192.00
80,474.00
Net Income from Continuing Operation Net Minority Interest
196,605.00
210,319.00
137,111.00
123,206.00
115,995.00
Total Unusual Items Excluding Goodwill
-2,198.00
2,937.00
2,842.00
-1,271.00
-3,605.00
Total Unusual Items
-2,198.00
2,937.00
2,842.00
-1,271.00
-3,605.00
Normalized EBITDA
454,704.00
445,774.00
292,051.00
272,156.00
233,779.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-430.53
588.21
610.97
-234.95
-777.01
12/31/2020 - 12/29/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4129.TWO United Orthopedic Corporation
94.10
-1.36%
4183.TWO EPS Bio Technology Corp.
22.60
-1.53%
6747.TWO Brighten Optix Corporation
138.50
+0.36%
4161.TWO Bioptik Technology Incorporation
33.30
-1.77%
1788.TWO Hi-Clearance Inc.
139.50
0.00%
4121.TWO Rossmax International Ltd.
16.10
-2.42%
4745.TWO Cowealth Medical Holding Co., Ltd.
20.30
-1.22%
4736.TW TaiDoc Technology Corporation
146.00
-0.68%
6767.TWO Wiltrom Co., Ltd.
32.75
+0.46%
1781.TWO Health & Life Co., Ltd.
17.15
-3.11%